Upstream Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Upstream Bio and other ETFs, options, and stocks.

About UPB

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin.

CEO

E. Rand Sutherland

CEOE. Rand Sutherland

Employees

Employees52

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2021

Founded2021

Employees

Employees52

UPB Key Statistics

Market cap

565.37M

Market cap565.37M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

398.15K

Average volume398.15K

High today

$10.58

High today$10.58

Low today

$9.25

Low today$9.25

Open price

$9.29

Open price$9.29

Volume

333.97K

Volume333.97K

52 Week high

$29.46

52 Week high$29.46

52 Week low

$5.14

52 Week low$5.14

People also own

Based on the portfolios of people who own UPB. This list is generated using Robinhood data, and it’s not a recommendation.